National Security Podcast: US Government Zeros in on China
Compliance Perspectives: The FBI on Why and How to Work with the Office of the Private Sector
As part of the House’s “China Week”—focusing on legislation to curb threats from Beijing—the House passed the BIOSECURE Act (H.R. 8333) on September 9 with strong bipartisan support (in a 306–81 vote). If signed into law,...more
On September 9, 2024, the House of Representatives passed the BIOSECURE Act by 306 to 81 votes. Before the congressional recess, House Speaker Mike Johnson (R-LA) had announced he would bring the BIOSECURE Act (H.R. 8333) to...more
Last night, the House of Representatives passed the BIOSECURE Act (BIOSECURE or the Act) by a bipartisan vote of 306 to 81. The BIOSECURE Act prohibits federal agencies from procuring or obtaining any biotechnology...more
On July 8, 2024, House Speaker Johnson (R-LA) announced that he would bring the BioSecure Act (H.R. 8333) to the floor for a vote in the Fall. The bill, introduced earlier this year, seeks to halt federal contracts with...more
A House committee will vote May 15 on an updated version of the BIOSECURE Act, legislation that would block federal contracts to five Chinese biotechnology companies and other drugmakers with certain China-based companies in...more
FDI restrictions have been on the political agenda in Europe and further afield for at least the past year, and following the outbreak of COVID-19 and the changed economic landscape, the approach in jurisdictions across the...more